Clearance Summary
ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A) received FDA 510(k) clearance under submission number K210930, sponsored by Johnson & Johnson Vision Care, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Ophthalmic review panel. The statutory decision date of record is 2021-11-29.
- Submission: K210930
- Applicant / Sponsor: Johnson & Johnson Vision Care, Inc.
- Clearance pathway: Traditional
- Review panel: Ophthalmic
- Device class: Class II
- Regulation citation: 21 CFR 886.5925
- Decision date: 2021-11-29
Classification & Regulation
This clearance is catalogued under FDA product code LPL and 21 CFR 886.5925, within the Ophthalmic review panel as a Class II device.